Work

Clinical outcomes of patients with RTK-RAS pathway alterations by treatment type: The MD Anderson Cancer Center IMPACT 2 study.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.3151

Authors: Mehmet A. Baysal, Jacopo Venturini, Abhijit Chakraborty, Siqing Fu, David S. Hong, Sarina A. Piha-Paul, Aung Naing, Jordi Rodon Ahnert, Timothy A. Yap, Ecaterina Elena Dumbrava, Jennifer Beck, Clark Andersen, Michael Kahle, David J. Vining, Funda Meric-Bernstam, Apostolia Maria Tsimberidou

Institutions: The University of Texas MD Anderson Cancer Center, Azienda Ospedaliero-Universitaria Careggi

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Foundation Medicine

OpenAlex ID: W7162539433

Cites:

Cited by:

Related to: